Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to break down ...

Investment analysts at Wedbush cut their FY2025 EPS estimates for RH in a research report issued on Tuesday, February 18th.

Wedbush upped their FY2025 earnings estimates for shares of CarMax in a research report issued to clients and investors on ...

Investing.com -- Tesla's stock has faced continued pressure in 2025, but Wedbush analysts remain bullish, maintaining their ...

We recently compiled a list of the Top 10 AI Stocks on Wall Street’s Radar Right Now. In this article, we are going to take a ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange ...

Wedbush made a splash on Tuesday with the announcement that it was entering the ever-growing ETF market. Read more here.

In a report released today, Yun Zhong from Wedbush maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price ...

Palantir Technologies Inc (NASDAQ:PLTR) shares are trading lower Thursday, adding to losses from Wednesday due to the ...

Palantir (PLTR) stock is tumbling 11% after its CEO implemented a new stock-trading plan and a report stated that the ...

In today’s CEO Daily: Diane Brady with President Trump at FII in Miami. The big story: Trump v the World. The markets: ...

Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, ...